Lyell Immunopharma (LYEL) Shares Outstanding (Diluted) (2020 - 2026)
Lyell Immunopharma (LYEL) reported Shares Outstanding (Diluted) of 23.36 million for Q2 2026, up 57.9% from 14.79 million a year earlier and up 6.8% from the prior quarter.
Powered by 
Analysis
Lyell Immunopharma (LYEL) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
For FY2025, Lyell Immunopharma posted Shares Outstanding (Diluted) of 17.09 million, up 30.7% from FY2024.
- Shares Outstanding (Diluted) has increased for six consecutive years, with a five-year compound annual growth rate of 91.5% (FY2020 to FY2025).
- By year, Shares Outstanding (Diluted) came in at 13.07 million in FY2024 (+4.2%), 12.55 million in FY2023 (+1.6%), 12.35 million in FY2022 (+81.8%) and 6.8 million in FY2021 (+925.2%).
- The Q2 2026 figure ranks as the highest quarterly Shares Outstanding (Diluted) in data going back to Q2 2020.
- Year over year, Shares Outstanding (Diluted) has now increased in each of the last 17 quarters, with growth averaging 27.2% over the last eight quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding (Diluted) ranged from 1.2% (Q3 2023) to 925.2% (Q4 2021).
- Per Business Quant data, the three quarters before Q2 2026 came in at 21.88 million (Q1 2026), 17.09 million (Q4 2025) and 18.27 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Lyell Immunopharma | 220.17 Mn | 220.17 Mn | - | 23.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.36 Mn |
| Mar 31, 2026 | 21.88 Mn |
| Dec 31, 2025 | 17.09 Mn |
| Sep 30, 2025 | 18.27 Mn |
| Jun 30, 2025 | 14.79 Mn |
| Mar 31, 2025 | 14.75 Mn |
| Dec 31, 2024 | 13.07 Mn |
| Sep 30, 2024 | 12.82 Mn |
| Jun 30, 2024 | 12.77 Mn |
| Mar 31, 2024 | 12.71 Mn |
| Dec 31, 2023 | 12.55 Mn |
| Sep 30, 2023 | 12.57 Mn |
| Jun 30, 2023 | 12.51 Mn |
| Mar 31, 2023 | 12.48 Mn |
| Dec 31, 2022 | 12.35 Mn |
| Sep 30, 2022 | 12.42 Mn |
| Jun 30, 2022 | 12.32 Mn |
| Mar 31, 2022 | 12.21 Mn |
| Dec 31, 2021 | 6.80 Mn |
| Sep 30, 2021 | 11.97 Mn |
API Access
Lyell Immunopharma Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=LYEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "LYEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=LYEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();